For this month’s ANA Q&A, we are featuring ALS Awareness Month, and we spoke with Eva Feldman, MD, PhD, FANA. Dr. Feldman is the Russell N. DeJong Professor of Neurology at Michigan Medicine, where she also serves as Director of the ALS Center of Excellence and Director of the NeuroNetwork for Emerging Therapies.

For this month’s ANA Q&A, we spoke with Deanna Saylor, MD, MHS, Assistant Professor of Neurology at Johns Hopkins University School of Medicine who spends most of the year as a Visiting Consultant at the University Teaching Hospital (UTH) in Lusaka, Zambia.

In recognition of National Epilepsy Awareness Month (November), we spoke with Kimford J. Meador, MD, FANA, FAAN, FAES, FRCPE, for this month's ANA Q&A. Dr. Meador is a Professor of Neurology and Neurosciences at Stanford University, and Clinical Director, Stanford Comprehensive Epilepsy Center.

This month, the ANA talks with the recipient of the 2021 Distinguished Neurology Teacher Award, Robert Lisak, MD, FRCP, FAAN, FANA. Dr. Lisak is the Parker Webber Chair in Neurology, Professor of Neurology and of Biochemistry, Microbiology and Immunology at Wayne State University.

In this month’s ANA Q&A, we spoke with Tania Torbati, BSc, a student at Western University of Health Science in the College of Osteopathic Medicine of the Pacific and a Neurology & Neurosurgery Research Intern at Cedars-Sinai.

In this month’s ANA Q&A, the American Neurological Association (ANA) spoke with Eric Landsness, MD, PhD, assistant professor of Neurology at the Washington University Physicians. Dr.

For this month’s ANA Q&A, the ANA spoke with Nina Riggins, MD, PhD, a neurologist and associate professor at UCSF Health who specializes in headache medicine. Dr. Riggins discusses the public’s  misunderstanding of headaches, how treatments have greatly improved over the years, and more.

We spoke with ANA Past President David Holtzman, MD, the Andrew B. and Gretchen P.

ANA talked to Barbara S. Giesser, MD, FAAN, FANA, an internationally recognized clinician who has specialized in the care of persons with multiple sclerosis (MS) since 1982. Dr.

"We initially began examining the role of environmental pollution on ALS because of the high rates of ALS in the state of Michigan. Michigan’s economy has traditionally relied heavily on industries that produce large amounts of pollution such as automotive and defense manufacturing as well as agriculture.